| 产品名称: | Serratia marcescens Bizio |
|---|---|
| 商品货号: | TS160513 |
| Deposited As: | Erythrobacillus fuchsinius |
| Strain Designations: | AMC R. Breed 121 F |
| Application: | Produces aspartylglucosaminidase aspartylglucosylamine deaspartylase, N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase |
| Biosafety Level: | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format: | freeze-dried |
| Storage Conditions: | 2°C to 8°C |
| Preceptrol®: | no |
| Type Strain: | no |
| Comments: | Vp negative |
| Medium: | ATCC® Medium 3: Nutrient agar or nutrient broth |
| Growth Conditions: | Temperature: 26.0°C Atmosphere:xa0 Aerobicxa0 |
| Name of Depositor: | AMC - Walter Reed Army Medical Center |
| References: | Mochizuki K, et al. Process for purifying L-asparaginase. US Patent 3,620,925 dated Nov 16 1971 Stern ML, et al. Physical properties of L-asparaginase from Serratia marcescens. J. Bacteriol. 125: 719-727, 1976. PubMed: 1107330 Boyd JW, Phillips AW. Purification and properties of L-asparaginase from Serratia marcescens. J. Bacteriol. 106: 578-587, 1971. PubMed: 4995652 |